Identification of aggrecanase activity in medium of cartilage culture

Journal of Biochemistry

Volumn 126, Issue 2, 1999, Pages 449-455

  Sugimoto, Kotaro ^a   Takahashi, Masaaki ^a   Yamamoto, Yumiko ^a   Shimada, Kohei ^a   Tanzawa, Kazuhiko ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Aggrecan; Aggrecanase; Cartilage culture; Joint disease; Matrix metalloproteinase

Indexed keywords

AGGRECANASE; CHONDROITIN SULFATE; HEPARIN; HYDROXAMIC ACID; METALLOPROTEINASE INHIBITOR; PROTEINASE; RETINOIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CATTLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; NOSE CARTILAGE; PROTEIN DOMAIN; PROTEIN PURIFICATION;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0032819417     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a022471     Document Type: Article

References (37)

1. Hardingham, T.E. and Fosang, A.J. (1992) Proteoglycans: many forms and many functions. FASEB J. 6, 861-870
2. Vertel, B.M. (1995) The ins and outs of aggrecan. Trend. Cell Biol. 5, 458-465
3. Hardingham, T.E. and Fosang, A.J. (1995) The structure of aggrecan and its turnover in cartilage. J. Rheumatol. Suppl. 43, 86-90
4. Kempson, G. (1980) The mechanical properties of articular cartilage in The Joints and Synovial Fluid (Sokolof, L., ed.) Vol. 2, pp. 177-238, Academic Press, New York
5. Sandy, J.D., Neame, P.J., Boynton, R.E., and Flannery, C.R. (1991) Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J. Biol. Chem. 266, 8683-8685
6. Loulakis, P., Shrikhande, A., Davis, G., and Maniglia, C.A. (1992) N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular-cartilage cultures. Putative site(s) of enzymic cleavage. Biochem. J. 284, 589-593
7. Hughes, C.E., Caterson, B., Fosang, A.J., Roughley, P.J., and Mort, J.S. (1995) Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem. J. 305, 799-804
8. Ilic, M.Z., Mok, M.T., Williamson, O.D., Campbell, M.A., Hughes, C.E., and Handley, C.J. (1995) Catabolism of aggrecan by explant cultures of human articular cartilage in the presence of retinoic acid. Arch. Biochem. Biophys. 322, 22-30
9. Lark, M.W., Gordy, J.T., Weidner, J.R., Ayala, J., Kimura, J.H., Williams, H.R., Mumford, R.A., Flannery, C.R., Carlson, S.S., Iwata, M., et al. (1995) Cell-mediated catabolism of aggrecan. Evidence that cleavage at the "aggrecanase" site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain. J. Biol. Chem. 270, 2550-2556
10. Sandy, J.D., Flannery, C.R., Neame, P.J., and Lohmander, L.S. (1992) The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J. Clin. Invest. 89, 1512-1516
11. Lohmander, L.S., Neame, P.J., and Sandy, J.D. (1993) The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum. 36, 1214-1222
12. Lark, M.W., Bayne, E.K., and Lohmander, L.S. (1995) Aggrecan degradation in osteoarthritis and rheumatoid arthritis. Acta Orthop. Scand. Suppl. 266, 92-97
13. Buttle, D. J., Bramwell, H., and Hollander, A.P. (1995) Proteolytic mechanism of cartilage breakdown: a target for arthritis therapy? J. Clin. Pathol. 48, M167-M177
14. Beckett, R.P. and Whittaker, M. (1998) Matrix metalloproteinase inhibitors 1998. Exp. Opin. Ther. Patents 8, 259-282
15. Bailey, S., Bolognese, B., Buckle, D.R., Faller, A., Jackson, S., Louis-Flamberg, P., McCord, M., Mayer, R.J., Marshall, L.A., and Smith, D.G. (1998) Selective inhibition of low affinity IgE receptor (CD23) processing. Bioorg. Med. Chem. Lett. 8, 29-34
16. Anderson, I.C., Shipp, M.A., Docherty, A.J., and Teicher, B.A. (1996) Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma. Cancer Res. 56, 715-718
17. Hardingham, T.E. (1979) The role of link-protein in the structure of cartilage proteoglycan aggregates. Biochem. J. 177, 237-247
18. Nagase, H. and Woessner, J.F., Jr. (1980) An improved assay for proteases and polysaccharidases employing a cartilage proteoglycan substrate entrapped in polyacrylamide particles. Anal. Biochem. 107, 385-392
19. Murphy, G. and Willenbrock, F. (1995) Tissue inhibitors of matrix metalloendopeptidases in Methods in Enzymology (Barrett, A.J., ed.) Vol. 248, pp. 496-510, Academic Press, New York
20. Gisslow, M.T. and McBride, B.C. (1975) A rapid sensitive collagenase assay. Anal Biochem. 68, 70-78
21. Knight, C.G., Willenbrock, F., and Murphy, G. (1992) A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 296, 263-266
22. Kleiner, D.E. and Stetler-Stevenson, W.G. (1994) Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218, 325-329
23. Chin, J.R., Murphy, G., and Werb, Z. (1985) Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. J. Biol. Chem. 260, 12367-12376
24. Flannery, C.R. and Sandy, J.D. (1993) Aggrecan catabolism in cartilage: studies on the nature of a novel proteinase (aggrecanase) which cleaves the Glu373-Ala374 bond of the interglobular domain. Orthop. Trans. 17, 677
25. Sandy, J.D., Plaas, A.H., and Koob, T.J. (1995) Pathways of aggrecan processing in joint tissues. Implications for disease mechanism and monitoring. Acta Orthop. Scand. Suppl. 266, 26-32
26. Dean, D.D., Martel-Pelletier, J., Pelletier, J.P., Howell, D.S., and Woessner, J.F., Jr. (1989) Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J. Clin. Invest. 84, 678-685
27. Wolfe, G.C., MacNaul, K.L., Buechel, F.F., McDonnell, J., Hoerrner, L.A., Lark, M.W., Moore, V.L., and Hutchinson, N.I. (1993) Differential in vivo expression of collagenase messenger RNA in synovium and cartilage. Quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis [see comments]. Arthritis Rheum. 36, 1540-1547
28. Fosang, A.J., Last, K., Neame, P.J., Murphy, G., Knauper, V., Tschesche, H., Hughes, C.E., Caterson, B., and Hardingham, T.E. (1994) Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan. Biochem. J. 304, 347-351
29. Büttner, F.H., Hughes, C.E., Margerie, D., Lichte, A., Tschesche, H., Caterson, B., and Bartnik, E. (1998) Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan. Biochem. J. 333, 159-165
30. Murphy, G., Allan, J.A., Willenbrock, F., Cockett, M.I., O'Connell, J.P., and Docherty, A.J. (1992) The role of the C-terminal domain in collagenase and stromelysin specificity. J. Biol. Chem. 267, 9612-9618
31. Murphy, G., Willenbrock, F., Ward, R.V., Cockett, M.I., Eaton, D., and Docherty, A.J. (1992) The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases [published erratum appears in Biochem. J. 1992 Jun 15;284(Pt 3):935]. Biochem. J. 283, 637-641
32. Moss, M.L., Jin, S.L., Milla, M.E., Bickett, D.M., Burkhart, W., Carter, H.L., Chen, W.J., Clay, W.C., Didsbury, J.R., Hassler, D., Hoffman, C.R., Kost, T.A., Lambert, M.H., Leesnitzer, M.A., McCauley, P., McGeehan, G., Mitchell, J., Moyer, M., Pahel, G., Rocque, W., Overton, L.K., Schoenen, F., Seaton, T., Su, J.L., Becherer, J.D., et al. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha [published erratum appears in Nature 1997 Apr 17;386(6626): 738]. Nature 385, 733-736
33. Tortorella, M.D., Pratta, M.A., Fox, J.W., and Arner, E.C. (1998) The interglobular domain of cartilage aggrecan is cleaved by hemorrhagic metalloproteinase HT-d (atrolysin C) at the matrix metalloproteinase and aggrecanase sites. J. Biol. Chem. 273, 5846-5850
34. McKie, N., Edwards, T., Dallas, D.J., Houghton, A., Stringer, B., Graham, R., Russell, G., and Croucher, P.I. (1997) Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytes. Biochem. Biophys. Res. Commun. 230, 335-339
35. Kuno, K., Kanada, N., Nakashima, E., Fujiki, F., Ichimura, F., and Matsushima, K. (1997) Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J. Biol. Chem. 272, 556-562
36. Arner, E.C., Pratta, M.A., Trzaskos, J.M., Decicco, C.P., and Tortorella, M.D. (1999) Generation and characterization of aggrecanase. A soluble, cartilage-derived aggrecan-degrading activity. J. Biol. Chem. 274, 6594-6601
37. Tanzawa, K., Ishii, M., Ogita, T., and Shimada, K. (1992) Matlystatins, new inhibitors of typeIV collagenases from Actinomadura atramentaria. II. Biological activities. J. Antibiot. (Tokyo) 45, 1733-1737